PFIZER CANADA ULC/PFIZER CANADA SRI
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Discuss Product Listing Agreements of Pfizer Innovative Medicine products with BC Pharmacare
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Provide supply chain availability updates on Pfizer medicines, including vaccines, deemed essential for COVID-19 acute and community care
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19
|
|
Seeking reimbursement for Pfizer oncology medicines through the BC Cancer systemic drug therapy program under the Provincial Health Services Authority
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Through Innovative Medicines of Canada (IMC) to further promote the contributions and positive impact of the pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
To provide information and learn more about the Ministry of Health's needs and requirements for the administration and distribution of a COVID 19 vaccine strategy.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19
|